Increased isolation of MDR Salmonella and Campylobacter spp.
from poultry has caused resurgence in bacteriophage therapy as a
natural antimicrobial alternative. Although approval in the United
States for on the farm use of bacteriophages has yet to be granted,
the research in this area is proving valuable, showing that reducing
these two pathogens, pre-slaughter, is possible and deserving of
further investigation. Further work is also needed to validate the
effectiveness of commercially available, federally approved, bacteriophage
application in posteslaughter poultry processing as well
as consumer acceptability. Overall, bacteriophages are a plausible
alternative for controlling Salmonella and Campylobacter in poultry
processing. However, streamlined, replicable studies that is effective
in intensive animal husbandry and is worth the cost to poultry
producers and processors, is required before bacteriophages
become a widespread, commercially applicable, and antimicrobial